Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
imu-838 (1 trial)
ondansetron (zofran) (1 trial)
oseltamivir (tamiflu) (1 trial)
Hallucinations (Phase 2)
Parkinson Disease (Phase 2)
Trials (2 total)
Trial APIs (3 total)